Indian pharmaceutical companies play a crucial role in providing, supplying, and offering effective, affordable, and high-quality assured antiretroviral (ARV) medications to South Africa and other developing countries such as Nigeria, Ghana, Kenya, Zambia, Japan, and Cambodia. This significantly lowers costs and expands access to antiretroviral treatment in the fight against HIV and AIDS.
This important contribution has enabled the large-scale expansion of the human immunodeficiency virus (HIV) program, with Indian generics often supplying the majority of AIDS medications. In this blog, we i
Facing issue in account approval? email us at info@ipt.pw
Sunrise Remedies Pvt. Ltd., based in Ahmedabad, Gujarat, is a leading manufacturing pharmaceutical company for the minoxidil topical solution and tablet for hair regrowth.
Sunrise Remedies is popular for manufacturing “Minosun” brand products for various types of hair loss in men and women. It functions by enlarging blood vessels and increasing blood circulation to hair follicles and balding areas; it can help in regaining growth.
We have Minosun Tablet, Minosun Solution, Minosun-F Solution, and Minosun-AT Topical Solution with ISO 9001:2015 and WHO-GMP certificates.
Sunrise Remedies is popular for manufacturing “Minosun” brand products for various types of hair loss in men and women. It functions by enlarging blood vessels and increasing blood circulation to hair follicles and balding areas; it can help in regaining growth.
We have Minosun Tablet, Minosun Solution, Minosun-F Solution, and Minosun-AT Topical Solution with ISO 9001:2015 and WHO-GMP certificates.
Daclarise is a medication manufactured by Sunrise Remedies Pvt. Ltd. that contains the active ingredient daclatasvir. It is an antiviral medication used to treat adults with chronic hepatitis C (CHC).
Daclatasvir works by inhibiting the HCV NS5A protein, a crucial component for hepatitis C virus (HCV) replication and assembly. It binds to the N-terminus within NS5A's Domain 1, thereby disrupting the formation of the viral replication complex and preventing the assembly of new viral particles. This dual action of inhibiting both viral RNA replication and virion assembly leads to a signific
Daclatasvir works by inhibiting the HCV NS5A protein, a crucial component for hepatitis C virus (HCV) replication and assembly. It binds to the N-terminus within NS5A's Domain 1, thereby disrupting the formation of the viral replication complex and preventing the assembly of new viral particles. This dual action of inhibiting both viral RNA replication and virion assembly leads to a signific